Monday, October 26, 2026 · Daily editionET --:--:--

Finished

A Single Center Clinical Evaluation of Same Sitting Hybrid Revascularization: Robotic Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention for the Treatment of Coronary Artery Disease

NCT00928356 · Pinnacle Health Cardiovascular Institute · Updated 11 May 2020

What is being tested
Hybrid CABG/PCI; Off Pump CABG
For
Coronary Artery Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 88 people. The full rules are on the registry page.
Where
United States
When
Starts or started 14 Oct 2008, ends 13 Aug 2019. Registered 25 June 2009.
Results
None posted yet.

In the researchers' words

The primary objective of this study is to assess the safety and effectiveness of same sitting, simultaneous hybrid robotic assisted coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in the treatment of obstructive multivessel coronary artery disease. A secondary objective is the assessment and standardization of optimal operator techniques and comparative study of patients undergoing CABG during study period.
ClinicalTrials.gov, NCT00928356

Sites

  • UPMC Pinnacle HarrisburgHarrisburg, Pennsylvania, United States